Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | Suppliers

InPheno - Quality Services in Drug Discovery

InPheno is a Swiss company providing custom antivirals testing services from screening and lead optimisation support, to candidate profiling and mode of action. We strive to be the one-stop solution for your needs in research and profiling of antiviral drug candidates in the field of HIV, hepatitis, and respiratory viruses.

Flexible antiviral development solutions

We act as an extension of your drug development team and offer a flexible solution that gives you real value whether you are a small biotech company or a large pharmaceutical organisation. InPheno is dedicated to applying the highest standards of science and quality to any work we do. We are committed to integrity and confidentiality, and we offer an interactive relationship with our clients and partners.

Expertise in molecular and cellular assay technology

Our team are specialists in the fields of virology and assay development and between them have several years of experience in the pharmaceutical industry. Our scientists possess a wide range of expertise in molecular and cellular assay technology alongside considerable knowledge in the development of modern therapeutics. Our expertise assists our customers in developing new medicines for the treatment of life-threatening diseases.

Service Models:

  • Fee-for-service: For many years InPheno has been providing services to internationally operating companies as well as to smaller ones located in the USA and Canada, and in various European, Asian, and African countries.
  • Grant Collaborations: In this model, InPheno works as a collaborative research organization. We have contributed to collaborations with companies or academic groups seeking funds from public bodies or private sources.
  • Partnership: InPheno is open to collaborations on a risk-benefit sharing basis. In this model, the cost of our services is covered by a percentage of the intellectual property rights of the compound(s). Hence, the partner and InPheno will negotiate binding contracts with the aim to share the risk and the benefit of developing antivirals.

Contact

InPheno
Vesalgasse 1
CH-4051 Basel
Switzerland
Email: info@inpheno.com
URL: www.inpheno.com